Professional Status:
Private Practice - Group/Partnership, Full-Time
Awards and Honors:
2006, Charles E. Clifton Leadership Award: Test Positive Aware Network "For Excellence & Leadership to the Chicago HIV Community"
May 2000, Distinguished Researcher in HIV Medicine, Serono Laboratories
April 2006, Preceptor Award, Recognition of Outstanding Teaching in Internal Medicine, American College of Physicians
Professional Affiliations/Memberships:
Member, Illinois State Medical Society
Member, Chicago Medical Society
Member, American Medical Association
Member, American College of Physicians
Member, American Academy of HIV Medicine
American College of Nutrition
Committees:
AIDS Foundation of Chicago, Member, Board of Directors
Medical Issues Committee for Illinois AIDS Drug Assistance Program, Medical Advisory
Publications:
Feb. 2007, Effects of TH9507, a Growth Hormone Releasing Factor (GRF) Analog, on HIV-associated abdominal fat accumulation: A Multicenter, Double-blind Placebo-controlled Trial with 412 Randomized Patients., LB (Late-Breaker); 14th Conference on Retroviruses and Opportunistic Infections (CROI) Los Angeles
2007, The HIV integrase inhibitor GS-9137 has potent antiretroviral activity in treatment-experienced patients [Abstract 143LB], 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, 2007.
2007, Week 24 Efficacy and Safety of TMC114/ritonavir in treatment-experienced HIV Patients., AIDS 2007, 21:F11-F18.
Mar 2007, Efficacy and Safety of TMC125 in Patients with Highly Resistant HIV-1: Primary 24-week Analysis of trial TMC125-C223., AIDS 21(6): F1-F10, March 2007.
July 2007, Comparison of 48 week efficacy and safety of darunavir/ritonavir (DRV/r) with lopinavir/ritonavir (LPV/r) in LPV/r-naïve, treatment experienced, patients: a randomized, controlled phase III trial (TIITAN)., 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Sidney, Australia, 22-25 July 2007.
July 2007, Once-daily abacavir/lamivudine (ABC/3TC) and boosted Atazanavir (ATV/RTV) in antiretroviral-naïve HIV-1 infected subjects: 48-week results from COL102060 (SHARE);, 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Sidney, Australia, 22-25 July 2007.
2007, TIITAN: A Randomized, Controlled Phase III Trial Compariing 48-week Efficacy and Safety of Darunavir/Ritonavir (DRV/r) with Lopinavir/Ritonavir (LPV/r) in treatment experienced patients., The Lancet 2007; 370:49-58
Professional Interests:
Board Member, The Joel Hall Dancers, Board Member, Intuit, The Center for Intuitive and Outsider Art
Physician Treats:
HIV positive
Patient / Medical Philosophy
Dr. Daniel S. Berger offers Chicago our new state-of-the-art medical and research center, as we continue to
provide our well-known brand of individualized HIV and Primary care.
Experience / Training
Medical School:
Rosalind Franklin University of Medicine and Science/ The Chicago Medical School North Chicago, IL 1986
Internship:
Advocate Lutheran General Hospital Park Ridge, IL 1988
Residency:
Saint Joseph Hospital Chicago, 1990
Positions:
University of Illinois at Chicago, Clinical Assistant Professor of Medicine
Chicago, IL
Undergraduate School:
Touro College New York, NY
Professional Status:
Private Practice - Group/Partnership
Disciplinary Actions
HealthGrades has examined disciplinary actions within the last five years from the Office of Inspector General and 50 state medical boards.
HealthGrades could not detect any disciplinary actions for Dr. Daniel S. Berger, MD
as of 07/10/2009. Note: HealthGrades reports on state and federal disciplinary actions (if any) from the previous five years.
Malpractice History
HealthGrades did not find any closed malpractice claims for
Dr. Daniel S.
Berger, MD
in the states of California, Connecticut, Florida, Georgia, Idaho, Indiana, Massachusetts, Maryland, North Dakota, New Jersey, New York, Oregon, Tennessee, Texas, Virginia, Vermont, or West Virginia.
Learn More
Note: HealthGrades obtains physician information from a variety of sources. Some information that is not designated as HealthGrades verified has been reported by the physician.
We comply with the HONcode standard for trustworthy health information. Verify here.
